Published in Neurology on May 27, 2003
The Oslo definitions for coeliac disease and related terms. Gut (2012) 5.76
Clinical utility of serologic testing for celiac disease in asymptomatic patients: an evidence-based analysis. Ont Health Technol Assess Ser (2011) 0.86
An unusual cause of adult onset cerebellar ataxia with hypogonadism. Ann Indian Acad Neurol (2009) 0.86
Motor neuronopathy with dropped hands and downbeat nystagmus: a distinctive disorder? A case report. BMC Neurol (2006) 0.84
The many faces of celiac disease. Gastroenterol Hepatol (N Y) (2011) 0.81
Antigliadin antibody in an ataxic patient with no other evidence of celiac sprue. Gastroenterol Hepatol (N Y) (2007) 0.78
Acquired ataxias: the clinical spectrum, diagnosis and management. J Neurol (2015) 0.77
Downbeat nystagmus, ataxia and spastic tetraparesis due to coeliac disease. Neurol Sci (2011) 0.77
Neurologic manifestations of celiac disease: proven, or just a gut feeling? Neurology (2003) 0.76
Antigliadin antibody in sporadic adult ataxia. Iran J Neurol (2012) 0.75
Serology of celiac disease in gluten-sensitive ataxia or neuropathy: role of deamidated gliadin antibody. J Neuroimmunol (2010) 0.75
Coeliac disease patients do not produce antibodies to a common cerebellar epitope. Cerebellum Ataxias (2014) 0.75
Prevalence of antigliadin antibodies in ataxia patients. Neurology (2004) 0.75
Further Evidence for Celiac Disease-associated Chorea. Tremor Other Hyperkinet Mov (N Y) (2011) 0.75
Autoimmunity as a prognostic factor in sporadic adult onset cerebellar ataxia. J Neurol (2011) 0.75
A greedy algorithm for aligning DNA sequences. J Comput Biol (2000) 47.89
Comparative analyses of multi-species sequences from targeted genomic regions. Nature (2003) 13.31
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet (1998) 12.92
Second consensus statement on the diagnosis of multiple system atrophy. Neurology (2008) 7.27
Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology (2006) 6.44
arrow encodes an LDL-receptor-related protein essential for Wingless signalling. Nature (2000) 5.13
Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci (1999) 5.01
Socioeconomic status and psychiatric disorders: the causation-selection issue. Science (1992) 4.95
A new human prostate carcinoma cell line, 22Rv1. In Vitro Cell Dev Biol Anim (1999) 4.93
Comparative sequence analysis of a gene-rich cluster at human chromosome 12p13 and its syntenic region in mouse chromosome 6. Genome Res (1998) 3.80
Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting centre on human chromosome 15. Nat Genet (1995) 3.79
The action of gamma-aminobutyric acid on cortical neurones. Exp Brain Res (1967) 3.45
Structure of chromosomal duplicons and their role in mediating human genomic disorders. Genome Res (2000) 3.30
AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function. J Clin Endocrinol Metab (2003) 3.19
Declining HIV/AIDS mortality in New York City. J Acquir Immune Defic Syndr (1999) 3.01
Comparative analysis of the gene-dense ACHE/TFR2 region on human chromosome 7q22 with the orthologous region on mouse chromosome 5. Nucleic Acids Res (2001) 2.89
Functional neuroanatomical correlates of hysterical sensorimotor loss. Brain (2001) 2.75
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet (2004) 2.75
The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol (1998) 2.72
Chromosome breakage in the Prader-Willi and Angelman syndromes involves recombination between large, transcribed repeats at proximal and distal breakpoints. Am J Hum Genet (1999) 2.71
CACP, encoding a secreted proteoglycan, is mutated in camptodactyly-arthropathy-coxa vara-pericarditis syndrome. Nat Genet (1999) 2.60
Pain reduction in local anesthetic administration through pH buffering. Ann Emerg Med (1988) 2.59
Mutations in the novel protocadherin PCDH15 cause Usher syndrome type 1F. Hum Mol Genet (2001) 2.48
The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria. Pediatrics (2001) 2.37
Globin gene server: a prototype E-mail database server featuring extensive multiple alignments and data compilation for electronic genetic analysis. Genomics (1994) 2.36
Bilateral human fetal striatal transplantation in Huntington's disease. Neurology (2002) 2.34
Intensive coordinative training improves motor performance in degenerative cerebellar disease. Neurology (2009) 2.33
Emotional facial expressions capture attention. Neurology (2001) 2.25
Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulin. Diabetes Obes Metab (2012) 2.19
Evaluation of mental retardation: recommendations of a Consensus Conference: American College of Medical Genetics. Am J Med Genet (1997) 2.19
CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar. Cancer Res (1996) 2.18
Molecular genetic alterations in glioblastomas with oligodendroglial component. Acta Neuropathol (2001) 2.17
Image-guided transorbital roof craniotomy via a suprabrow approach: a surgical series of 72 patients. Neurosurgery (2001) 2.13
The natural history of degenerative ataxia: a retrospective study in 466 patients. Brain (1998) 2.11
The effect of severe caries on the quality of life in young children. Pediatr Dent (1999) 2.10
High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia. Neurology (2006) 2.09
KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression. Oncogene (2006) 2.07
The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study. Neurology (2011) 2.06
Identification of centromeric antigens in dicentric Robertsonian translocations: CENP-C and CENP-E are necessary components of functional centromeres. Hum Mol Genet (1995) 2.04
Oxidative stress in patients with Friedreich ataxia. Neurology (2000) 2.03
QALYs for resource allocation: a reply to Burrows and Brown. Aust J Public Health (1993) 1.97
The mosaic structure of human pericentromeric DNA: a strategy for characterizing complex regions of the human genome. Genome Res (2000) 1.97
An analysis of lamellar x-ray diffraction from disordered membrane multilayers with application to data from retinal rod outer segments. Biophys J (1975) 1.97
Macular full-thickness and lamellar holes in association with type 2 idiopathic macular telangiectasia. Eye (Lond) (2008) 1.96
Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients. Brain (2009) 1.91
Pervasive occult gastrointestinal bleeding in an Alaska native population with prevalent iron deficiency. Role of Helicobacter pylori gastritis. JAMA (1997) 1.89
Translational inhibition in vitro of human papillomavirus type 16 L2 mRNA mediated through interaction with heterogenous ribonucleoprotein K and poly(rC)-binding proteins 1 and 2. J Biol Chem (1998) 1.88
Difficult extubation due to transfixation of a nasotracheal tube by a Kirschner wire. Anesthesiology (1977) 1.88
A novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteins. J Virol (1990) 1.87
BAC microarray analysis of 15q11-q13 rearrangements and the impact of segmental duplications. J Med Genet (2004) 1.87
Transmission of a balanced homologous t(22q;22q) translocation from mother to normal daughter. Clin Genet (1980) 1.84
Relation of serum total cholesterol and high-density lipoprotein cholesterol percentage to the incidence of definite coronary events: twenty-year follow-up of the Donolo-Tel Aviv Prospective Coronary Artery Disease Study. Am J Cardiol (1987) 1.78
A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy. J Clin Invest (1998) 1.77
CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma. Cancer Res (1994) 1.77
Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype. Ann Neurol (1999) 1.74
Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clin Auton Res (1998) 1.71
Public knowledge, attitudes, and beliefs about homeless people: evidence for compassion fatigue. Am J Community Psychol (1995) 1.69
Decentralizing a community mental health center's service delivery system. Hosp Community Psychiatry (1974) 1.68
Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis. Arch Neurol (2001) 1.67
Validation of a new quality of life questionnaire for benign prostatic hyperplasia. J Clin Epidemiol (1992) 1.65
Relationship of depressive symptoms to hypertension in a household survey in Harlem. Psychosom Med (2001) 1.61
Characterization of neo-centromeres in marker chromosomes lacking detectable alpha-satellite DNA. Hum Mol Genet (1997) 1.60
Paroxysmal choreoathetosis/spasticity (DYT9) is caused by a GLUT1 defect. Neurology (2011) 1.58
Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease. Trends Neurosci (1989) 1.57
Potassium deprivation-induced apoptosis of cerebellar granule neurons: a sequential requirement for new mRNA and protein synthesis, ICE-like protease activity, and reactive oxygen species. J Neurosci (1996) 1.56
Angioblast differentiation and morphogenesis of the vascular endothelium in the mouse embryo. Dev Biol (1991) 1.56
Reduction of capsular polysaccharide production in Klebsiella pneumoniae by sodium salicylate. Infect Immun (1989) 1.56
Magnetic resonance imaging in hereditary and idiopathic ataxia. Neurology (1993) 1.55
The Spastic Paraplegia Rating Scale (SPRS): a reliable and valid measure of disease severity. Neurology (2006) 1.54
Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology (2008) 1.53
A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med (1990) 1.53
Micro-iontophoretic studies on neurones in the cuneate nucleus. J Physiol (1967) 1.53
Quantitative Differentiation of Minute Amounts of the Coproporphyrin Isomers (I and III) Based on Fluorescence Behavior. Science (1946) 1.50
Molecular cloning and characterization of 2B7, a rat mRNA which distinguishes smooth muscle cell phenotypes in vitro and is identical to osteopontin (secreted phosphoprotein I, 2aR). Biochem Biophys Res Commun (1991) 1.48
Cell death and apoptosis regulating proteins in Parkinson's disease--a cautionary note. Acta Neuropathol (1999) 1.48
Mosaic trisomy 22: a case presentation and literature review of trisomy 22 phenotypes. Am J Med Genet (1997) 1.47
THE CONVERSION OF HEMATIN TO BILIRUBIN FOLLOWING INTRAVENOUS ADMINISTRATION IN HUMAN SUBJECTS. J Clin Invest (1945) 1.46
Molecular and cytogenetic analysis of familial Xp deletions. Am J Med Genet (2000) 1.45
STUDIES OF COPROPORPHYRIN. I. THE PER DIEM EXCRETION AND ISOMER DISTRIBUTION OF COPROPORPHYRIN IN NORMAL HUMAN URINE. J Clin Invest (1949) 1.45
Experimental aspects of peripheral vascular occlusion of the intestine. Surg Gynecol Obstet (1965) 1.45
Evidence for a Turner syndrome locus or loci at Xp11.2-p22.1. Am J Hum Genet (1998) 1.44
Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Ann Neurol (1999) 1.44
Somatic mutations in the DNA damage-response genes ATR and CHK1 in sporadic stomach tumors with microsatellite instability. Cancer Res (2001) 1.43
Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis. Oncogene (2006) 1.43
Molecular cytogenetic analysis of eight inversion duplications of human chromosome 13q that each contain a neocentromere. Am J Hum Genet (2000) 1.42
Molecular cytogenetic analysis of inv dup(15) chromosomes, using probes specific for the Prader-Willi/Angelman syndrome region: clinical implications. Am J Hum Genet (1994) 1.42
Double-blind crossover trial of trimethoprim-sulfamethoxazole in spinocerebellar ataxia type 3/Machado-Joseph disease. Arch Neurol (2001) 1.42
Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT. J Neurol Neurosurg Psychiatry (1994) 1.41
The Rev protein of human immunodeficiency virus type 1 counteracts the effect of an AU-rich negative element in the human papillomavirus type 1 late 3' untranslated region. J Virol (1995) 1.40
The diffusion of information technology among health maintenance organizations. Health Care Manage Rev (2000) 1.39
Nutrition, lysosomal proteases, and protein breakdown. Nutrition (1996) 1.39
Spinocerebellar ataxia type 6: evidence for a strong founder effect among German families. Neurology (1999) 1.39
Effect of patch type on the cumulative irritation potential of 4 test materials. Am J Contact Dermat (2001) 1.39